BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS

July 24, 2020 Leave a comment 1,134 Views

BrainStorm Cell Therapeutics Inc, a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that it has successfully completed its first milestone in developing an innovative exosome-based platform-technology for the treatment severe COVID-19 infection. COVID-19 induced pneumonia ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: NurOwn®

BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS

Scientists explain regulation of extracellular vesicles by dephosphorylating Syntenin

Overcoming Chemoresistance via Extracellular Vesicle Inhibition

Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential

Study focuses on a different kind of liquid biopsy to detect cancer

Raman spectral signatures of serum-derived EVs may serve as liquid biopsy for diagnosis of CNS tumors

Extracellular vesicles isolated from milk can improve gut barrier dysfunction induced by malnutrition